Therapy for Severe Psoriasis E-Book
Expert Consult
Nonfiction, Health & Well Being, Medical, Specialties, Dermatology, Family & General Practice
| Author: | Jashin J. Wu, MD, FAAD, Mark G. Lebwohl, M.D., Ph.D., Steven R. Feldman, MD, PhD | ISBN: | 9780323447980 |
| Publisher: | Elsevier Health Sciences | Publication: | December 2, 2016 |
| Imprint: | Elsevier | Language: | English |
| Author: | Jashin J. Wu, MD, FAAD, Mark G. Lebwohl, M.D., Ph.D., Steven R. Feldman, MD, PhD |
| ISBN: | 9780323447980 |
| Publisher: | Elsevier Health Sciences |
| Publication: | December 2, 2016 |
| Imprint: | Elsevier |
| Language: | English |
A brand-new title in the field of dermatology, ***Therapy for Severe Psoriasis***provides the ultimate coverage of the treatment options available for today's most serious cases, including biologics and oral therapies. It features discussions of the newest drug therapies, recent FDA-approved biosimilars, and combination approaches to care, while an overview chapter was designed to aid those new to the field in understanding the nuances of difficult-to-treat subtypes of psoriasis. Comprehensive and focused, Therapy for Severe Psoriasis will be a welcome addition to the library of any dermatologist seeking in-depth information on the challenges of this condition.
- Each of the 16 chapters includes either an in-depth focus on a single therapy or an overview of a unique aspect of psoriasis, including: UVB therapy, methotrexate, acitretin, cyclosporine, apremilast, etanercept, infliximab, adalimumab, ustekinumab, secukinumab, and ixekizumab.
- Takes an evidence-based approach to hard-to-treat severe psoriasis.
- Discusses the newest drug therapies (such as ixekizumab), plus recent FDA-approved biosimilars, a topic unique to this particular psoriasis text.
- Presents combination approaches for instances when standard treatments are not successful.
- Includes an overview chapter to help beginners understand the nuances of the disorder.
A brand-new title in the field of dermatology, ***Therapy for Severe Psoriasis***provides the ultimate coverage of the treatment options available for today's most serious cases, including biologics and oral therapies. It features discussions of the newest drug therapies, recent FDA-approved biosimilars, and combination approaches to care, while an overview chapter was designed to aid those new to the field in understanding the nuances of difficult-to-treat subtypes of psoriasis. Comprehensive and focused, Therapy for Severe Psoriasis will be a welcome addition to the library of any dermatologist seeking in-depth information on the challenges of this condition.
- Each of the 16 chapters includes either an in-depth focus on a single therapy or an overview of a unique aspect of psoriasis, including: UVB therapy, methotrexate, acitretin, cyclosporine, apremilast, etanercept, infliximab, adalimumab, ustekinumab, secukinumab, and ixekizumab.
- Takes an evidence-based approach to hard-to-treat severe psoriasis.
- Discusses the newest drug therapies (such as ixekizumab), plus recent FDA-approved biosimilars, a topic unique to this particular psoriasis text.
- Presents combination approaches for instances when standard treatments are not successful.
- Includes an overview chapter to help beginners understand the nuances of the disorder.
